Trained immunity enhances innate immune responses, yet a Western lifestyle may lead to maladaptive trained immunity and drive ...
Your immune system is your body’s built-in defense network, working nonstop to protect you from bacteria, viruses, and other ...
Unique platform designed to engage pro-resolution responses to restore immune homeostasis in inflammatory disorders without ...
New melanoma immunotherapy research reveals how changing the way tumors die can awaken immune defenses and improve outcomes in mice.
In A Nutshell Vaccinated adults over 70 showed cellular markers of slower aging compared to unvaccinated peers, including ...
GRI Bio, Inc. (NASDAQ: GRI) ("GRI Bio” or the "Company”), a biotechnology company advancing an innovative pipeline of immune ...
Olatec Therapeutics, Inc. ("Olatec"), a clinical stage biotechnology company leading the development of specific NLRP3 inhibitors, presented preclinical data at The Michael J. Fox Foundation (MJFF) ...
Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of ...
Your chances of catching a cold—and how miserable it feels—may depend more on your body than on the virus itself.
Across the world, only a few dozen people appear to carry a genetic glitch that lets them brush off viruses that flatten ...
PRESS RELEASEAB SCIENCE RECEIVES JAPANESE PATENT PROTECTION FOR THE USE OF MASITINIB IN PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS (MS) UNTIL ...
GRI's common stock is expected to begin trading on a post-split adjusted basis on January 26, 2026 LA JOLLA, CA, Jan. 21, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) ("GRI Bio" or the "Compan ...